Targeting Akt3 Signaling in Malignant Melanoma Using Isoselenocyanates

Abstract

Synthetic isoselenocyanates are therapeutically effective for inhibiting melanoma tumor development by targeting Akt3 signaling to increase apoptosis in melanoma cells with negligible associated systemic toxicity.